117 related articles for article (PubMed ID: 15552317)
1. Antiplatelet effects and pharmacodynamics of clopidogrel in cats.
Hogan DF; Andrews DA; Green HW; Talbott KK; Ward MP; Calloway BM
J Am Vet Med Assoc; 2004 Nov; 225(9):1406-11. PubMed ID: 15552317
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of antiplatelet effects of ticlopidine in cats.
Hogan DF; Andrews DA; Talbott KK; Green HW; Ward MP; Calloway BM
Am J Vet Res; 2004 Mar; 65(3):327-32. PubMed ID: 15027681
[TBL] [Abstract][Full Text] [Related]
3. Influence of a low dosage of clopidogrel on platelet function in cats as measured by the platelet function analyser PFA-100 and the multiplate analyser.
Teuber M; Mischke R
Res Vet Sci; 2016 Dec; 109():149-156. PubMed ID: 27892864
[TBL] [Abstract][Full Text] [Related]
4. Single-dose pharmacodynamics of clopidogrel.
Thebault JJ; Kieffer G; Cariou R
Semin Thromb Hemost; 1999; 25 Suppl 2():3-8. PubMed ID: 10440415
[TBL] [Abstract][Full Text] [Related]
5. Assessment of platelet function in healthy cats in response to commonly prescribed antiplatelet drugs using three point-of-care platelet function tests.
Ho KK; Abrams-Ogg AC; Wood RD; O'Sullivan ML; Kirby GM; Blois SL
J Feline Med Surg; 2017 Jun; 19(6):638-647. PubMed ID: 27170631
[TBL] [Abstract][Full Text] [Related]
6. Clopidogrel does not affect the pharmacokinetics of theophylline.
Caplain H; Thebault JJ; Necciari J
Semin Thromb Hemost; 1999; 25 Suppl 2():65-8. PubMed ID: 10440427
[TBL] [Abstract][Full Text] [Related]
7. The effects of laropiprant, a selective prostaglandin D₂ receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin.
Dallob A; Luo WL; Luk JM; Ratcliffe L; Johnson-Levonas AO; Schwartz JI; Dishy V; Kraft WK; De Hoon JN; Van Hecken A; De Lepeleire I; Radziszewski W; Wagner JA; Lai E
Platelets; 2011; 22(7):495-503. PubMed ID: 21526889
[TBL] [Abstract][Full Text] [Related]
8. Effects of clopidogrel therapy on whole blood platelet aggregation, the Plateletworks® assay and coagulation parameters in cats with asymptomatic hypertrophic cardiomyopathy: a pilot study.
den Toom ML; van Leeuwen MW; Szatmári V; Teske E
Vet Q; 2017 Dec; 37(1):8-15. PubMed ID: 27786603
[TBL] [Abstract][Full Text] [Related]
9. Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species.
Niitsu Y; Sugidachi A; Ogawa T; Jakubowski JA; Hashimoto M; Isobe T; Otsuguro K; Asai F
Eur J Pharmacol; 2008 Jan; 579(1-3):276-82. PubMed ID: 17996866
[TBL] [Abstract][Full Text] [Related]
10. Effects of clopidogrel and aspirin on platelet aggregation, thromboxane production, and serotonin secretion in horses.
Brainard BM; Epstein KL; LoBato D; Kwon S; Papich MG; Moore JN
J Vet Intern Med; 2011; 25(1):116-22. PubMed ID: 21143302
[TBL] [Abstract][Full Text] [Related]
11. Repeated-dose pharmacodynamics of clopidogrel in healthy subjects.
Thebault JJ; Kieffer G; Lowe GD; Nimmo WS; Cariou R
Semin Thromb Hemost; 1999; 25 Suppl 2():9-14. PubMed ID: 10440416
[TBL] [Abstract][Full Text] [Related]
12. Spaced administration of PA32540 and clopidogrel results in greater platelet inhibition than synchronous administration of enteric-coated aspirin and enteric-coated omeprazole and clopidogrel.
Gurbel PA; Bliden KP; Fort JG; Jeong YH; Shuldiner A; Chai S; Gesheff T; Antonino M; Gesheff M; Zhang Y; Tantry US
Am Heart J; 2013 Feb; 165(2):176-82. PubMed ID: 23351820
[TBL] [Abstract][Full Text] [Related]
13. Platelet Activation and Clopidogrel Effects on ADP-Induced Platelet Activation in Cats with or without the A31P Mutation in MYBPC3.
Li RH; Stern JA; Ho V; Tablin F; Harris SP
J Vet Intern Med; 2016 Sep; 30(5):1619-1629. PubMed ID: 27615120
[TBL] [Abstract][Full Text] [Related]
14. Protein disulphide isomerase-mediated LA419- NO release provides additional antithrombotic effects to the blockade of the ADP receptor.
Vilahur G; Pena E; Padró T; Badimon L
Thromb Haemost; 2007 Apr; 97(4):650-7. PubMed ID: 17393029
[TBL] [Abstract][Full Text] [Related]
15. Clopidogrel induces an acute hemostatic deficit and increases intra abdominal bleeding in rabbits.
Lortie E; Girard F; Boudreault D; Ruel M; Mansour S; Blais N; Hardy JF
Thromb Res; 2009 Apr; 123(6):869-73. PubMed ID: 19128824
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic and pharmacokinetic evaluation of clopidogrel and the carboxylic acid metabolite SR 26334 in healthy dogs.
Brainard BM; Kleine SA; Papich MG; Budsberg SC
Am J Vet Res; 2010 Jul; 71(7):822-30. PubMed ID: 20594086
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of antiplatelet effects of a modified protocol by platelet aggregation in patients undergoing "one-stop" hybrid coronary revascularization.
Gao P; Xiong H; Zheng Z; Li L; Gao R; Hu SS
Platelets; 2010; 21(3):183-90. PubMed ID: 20201634
[TBL] [Abstract][Full Text] [Related]
18. Clopidogrel loading dose regimens: kinetic profile of pharmacodynamic response in healthy subjects.
Savcic M; Hauert J; Bachmann F; Wyld PJ; Geudelin B; Cariou R
Semin Thromb Hemost; 1999; 25 Suppl 2():15-9. PubMed ID: 10440417
[TBL] [Abstract][Full Text] [Related]
19. Plateletworks: a screening assay for clopidogrel therapy monitoring in healthy cats.
Hamel-Jolette A; Dunn M; Bédard C
Can J Vet Res; 2009 Jan; 73(1):73-6. PubMed ID: 19337399
[TBL] [Abstract][Full Text] [Related]
20. Clopidogrel antiplatelet activity is independent of age and presence of atherosclerosis.
Denninger MH; Necciari J; Serre-Lacroix E; Sissmann J
Semin Thromb Hemost; 1999; 25 Suppl 2():41-5. PubMed ID: 10440422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
